Sol-Gel Technologies Ltd. ( SLGL) - Key Metrics
SLGL Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.25 | -$1.07 | ? | ? |
| 2025Q3 | $0.14 | -$2.13 | ? | ? |
| 2025Q2 | $6.20 | $4.17 | ? | ? |
| 2025Q1 | $0.04 | -$0.32 | ? | ? |
SLGL Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -9.83 |
| 2025Q3 | ? | -3.42 |
| 2025Q2 | ? | 0.44 |
| 2025Q1 | ? | -4.11 |
SLGL Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | ? |
| 2025Q3 | ? | ? |
| 2025Q2 | ? | ? |
| 2025Q1 | ? | ? |
SLGL
Price: $73.44
52 week price:
Earnings Per Share: -0.30 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: Israel
Volume: 22900
Market Capitalization: 219.1 million